top of page

Galafold

Client

Year

Audience

Disease 

Amicus

2018

Patients

Fabry Disease (Rare Lysosomal Disease)

Objective: Position Galafold, the first and only oral therapy available, as the the treatment that respects patients' time in a disease that is progressive and unpredictable. 

Tactics: Staged-approach website, library of educational print pieces, MOA videos, patient ambassador photoshoot, patient story videos, in-office educational materials, mailers and patient kits. 

Photorealistic Magazine MockUp 2.png
AMIGAL400909_IFUUpdate_V10_Page_1.jpg
AMIGAL_600566_FemaleBrochure_MechPrep3_P
AMIGAL 4001_GalafoldPatientBrochureRefre
AMIGAL_603402_VariabilityBrochure_MechPr
FlipCHart Mockup_B.png
FlipChart Mockup_P1.jpg
bottom of page